Davis Polk advises Payoneer on $2.75 billion sale to Nuvei
The all-cash transaction values Payoneer at $2.75 billion, with shareholders receiving $7.40 per share. Expected close in mid-2027.
See the latest news and media coverage for Davis Polk. We track all announcements, press releases, and industry mentions in real time, all in one place.
International law firm
davispolk.comLast updated
In short: Davis Polk advised on major transactions including SpaceX's $75 billion IPO and GSK's $10.6 billion acquisition of Nuvalent while eyeing expansion.
The all-cash transaction values Payoneer at $2.75 billion, with shareholders receiving $7.40 per share. Expected close in mid-2027.
The IPO comprised 70 million existing shares listed on Nasdaq Copenhagen, raising approximately DKK 1.05 billion.
The offering consisted of five tranches with maturities from 2029 to 2056, and the Davis Polk team included partners Alan F. Denenberg and Beth LeBow.
The court enforced discharge and injunction provisions against creditors seeking to pursue prepetition claims in Brazil.
In this week's Taxation With Representation, SpaceX prices a $75 billion initial public offering at its designated price range, Apollo Global Management leads a capital...
Pharma giant GSK PLC said Tuesday that it has agreed to acquire cancer therapy specialist Nuvalent Inc. for $10.6 billion as it seeks to accelerate...
Quantum computer developer Quantinuum hit the public markets on Thursday after raising $1.7 billion in its initial public offering steered by Latham & Watkins LLP...
Government contractor Applied Aerospace & Defense unveiled a targeted $634 million initial public offering steered by Kirkland & Ellis LLP and Davis Polk & Wardwell...
Track Davis Polk and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Davis Polk and other trending companies.